Insmed
INSM
$24.93
Share price
-2.04%
Change (1 day)
29.37%
Change (1 year)
Categories
Market capitalization of Insmed (INSM)
Market cap: $3.76 Billion
As of May 2024 Insmed has a market cap of $3.76 Billion. This makes Insmed the world's 3145th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Insmed from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $3.76 B | -15.19% |
| 2023 | $4.43 B | 63.79% |
| 2022 | $2.70 B | -16.05% |
| 2021 | $3.22 B | -4.92% |
| 2020 | $3.39 B | 58.35% |
| 2019 | $2.14 B | 111.15% |
| 2018 | $1.01 B | -57.53% |
| 2017 | $2.38 B | 191.71% |
| 2016 | $0.81 B | -27.03% |
| 2015 | $1.12 B | 45.61% |
| 2014 | $0.77 B | 15.81% |
| 2013 | $0.66 B | 215.84% |
| 2012 | $0.21 B | 178.12% |
| 2011 | $75.74 M | -23.29% |
| 2010 | $98.74 M | -1.51% |
| 2009 | $0.10 B | 75.33% |
| 2008 | $57.18 M | -43.14% |
| 2007 | $0.10 B | 12.79% |
| 2006 | $89.16 M | -31.96% |
| 2005 | $0.13 B | 32.75% |
| 2004 | $98.72 M | -13.43% |
| 2003 | $0.11 B | 665.29% |
| 2002 | $14.9 M | -88.16% |
| 2001 | $0.12 B |
End of Day market cap according to different sources
On May 15th, 2024 the market cap of Insmed was reported to be:
$3.76 Billion
$3.76 Billion
$3.70 Billion
$3.70 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $210.61 B | 5,501.33% | 🇨🇭 Switzerland |
 Gilead Sciences GILD | $83.48 B | 2,120.32% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $113.24 B | 2,911.92% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $12.52 B | 233.09% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | $0.75 B | -79.96% | 🇺🇸 USA |
 Array Technologies ARRY | $1.86 B | -50.44% | 🇺🇸 USA |